WILMINGTON, Del. - Relying on evidence that a patent defendant launched an infringing product even after an adverse ruling by the Federal Circuit U.S. Court of Appeals, a Delaware federal judge on March 13 agreed that an enhanced award was warranted (Boston Scientific Corporation and Boston Scimed Inc. v. Cordis Corporation, No. 10-315, D. Del.; 2012 U.S. Dist. LEXIS 33064).